Cargando…
Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
INTRODUCTION: B cells are attracting increasing attention in the pathogenesis of multiple sclerosis (MS). B cell-targeted therapies with monoclonal antibodies or plasmapheresis have been shown to be successful in a subset of patients. Here, patients with either relapsing-remitting (n = 24) or second...
Autores principales: | Hohmann, Christopher, Milles, Bianca, Schinke, Michael, Schroeter, Michael, Ulzheimer, Jochen, Kraft, Peter, Kleinschnitz, Christoph, Lehmann, Paul V, Kuerten, Stefanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177072/ https://www.ncbi.nlm.nih.gov/pubmed/25597707 http://dx.doi.org/10.1186/s40478-014-0138-2 |
Ejemplares similares
-
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2016) -
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients
por: Rovituso, Damiano M., et al.
Publicado: (2015) -
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
por: Rovituso, Damiano M., et al.
Publicado: (2016) -
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021) -
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
por: Kleist, Christian, et al.
Publicado: (2016)